PPBT Kitov Pharma: Accounting Value per Share

Public company logo of Purple Biotech Ltd (PPBT)

The investment potential of Purple Biotech is based on management's drive to commercialize methods for combating tumor resistance. The book value per common share illustrates capital dynamics, where the current value stands at 7.52. The foundation for success is built upon targeted developments recognized within the oncology community and strategic ownership of all patents, combined with the effective delegation of clinical trials to external partners.

Purple Biotech Ltd (PPBT) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for purple-biotech.com (PPBT)

- price and consensus price forecast:
Stock Price Purple Biotech Corp|PPBT - Price Target Chart
- market capitalization data:
Market Valuation Purple Biotech Ltd.|PPBT - Aggregate Business Value
- book capitalization data:
Book Value per Share Purple Biotech|PPBT - Company Net Assets|Market Capitalization to Book Value Ratio purple-biotech.com|PPBT - Company Total Assets
- debt and liquidity data:
Debt to Equity Purple Biotech|PPBT - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Purple Biotech Ltd.|PPBT - Company Total Debt|Debts to Book Capitalization Purple Biotech Ltd.
Analysis of all company metrics:Purple Biotech Corp, PPBT
Manufactured product of purple-biotech.com

Purple Biotech (PPBT) possesses significant pricing power in oncology due to the uniqueness of the CM24 antibody, creating substantial potential for the capitalization of intellectual assets. By analyzing the historical book value chart, an investor assesses the residual equity per share after all liabilities are settled, which allows for the determination of the business's intrinsic value and the mitigation of stagnation risks during periods of market consolidation.

Competitor analysis for Purple Biotech

ONC - Book Value per Share|Halozyme Corp (HALO) - Net Assets per Single Share|RVMD - Accounting Value per Share|ascentage.com (AAPG) - Book Price of a Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Accounting Value per Share|Accounting Value of a Share tuhurabio.com (HURA)|Protara - Book Value per Share|FATE - Accounting Value per Share|Aadi Bio - Accounting Value per Share|TCRX: Book Value per Share|Net Assets per Single Share championsoncology.com CSBR|XBiotech (XBIT) - Accounting Value of a Share|Book Value per Share CVM (CEL-SCI Corp.)|Net Asset Value per Share OSTX|RADX - Net Assets per Single Share|Share Book Value artivabio.com ARTV|Accounting Value per Share ANL (Adlai Nortye)|Veru Inc - Book Value per Share|Net Assets per Single Share Tempest Tx (TPST)|XLO: Accounting Value of a Share|Net Assets per Single Share renovarobio.com (RENB)|MURA (Mural Oncology) - Share Book Value|Net Assets per Single Share Kairos Pharma Limited|Net Assets per Single Share OnKure|CytoMed Therapeutics - Book Value per Share|Net Asset Value per Share curis.com CRIS|Accounting Value per Share Apollomics|Accounting Value of a Share tharimmune.com THAR|ADVB - Book Value per Share|GNPX - Net Assets per Single Share|calidibio.com - Book Value per Share|SBFM (Sunshine Biopharma Inc.) - Net Assets per Share|Net Assets per Single Share XBIO (Xenetic Biosciences Inc.)|Net Asset Value per Share salariuspharma.com (SLRX)|Accounting Value per Share American Oncology Network|Book Price of a Share BeiGene Ltd. (BGNE)|CKPT: Book Value per Share|Net Asset Value per Share elevationoncology.com ELEV|ICAD: Book Value per Share|IKNA - Accounting Value per Share|Book Value per Share Notable Labs NTBL|VIRX (Viracta Therapeutics, Inc.) - Accounting Value of a Share|Net Assets per Single Share MorphoSys Corp MOR|Share Book Value NAYA|AAPGV - Net Assets per Single Share